US › Healthcare

LifeMD Inc (LFMD)

US · Healthcare · Health Information Services

$3.90+4.56%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$50.2M
Revenue YoY
-23.6%
Net profit
$-8.9M
Profit YoY
-740.7%
EPS
$-0.15
EPS estimate
$-0.12
Net margin
-17.7%

EPS came in at -0.15 against a street estimate of -0.12 — a miss of 29.9%.

Key statistics

Market cap
$169.3M
Forward P/E
12.9
P/B
11.22
Book value
$0.32
EPS (TTM)
$-0.44
52-week high
$12.72
52-week low
$2.56
50-day MA
$4.43
200-day MA
$4.15
Beta
1.99

Analyst view

Analysts rate LifeMD Inc a strong buy (7 buy, 1 hold, 0 sell out of 8) with an average price target of $9.88.

Shareholding

Insiders
13.91%
Institutions
41.35%

Largest institutional holders

FundStake
BlackRock Inc5.81%
Vanguard Capital Management, LLC3.44%
Royce & Associates, LP2.48%
Renaissance Technologies Corp2.31%
State Street Corp2.22%
Geode Capital Management, LLC2.11%
Federated Hermes Inc2.11%
Prescott Group Capital Management LLC1.85%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for LifeMD Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.